Gene Editing & CRISPR in Cancer

Gene editing, especially CRISPR-Cas9, is revolutionizing cancer research and treatment by enabling precise modifications of cancer-related genes. This breakthrough technology allows scientists to correct genetic mutations, enhance immune cell function, and develop targeted therapies with greater accuracy. CRISPR is being explored for its potential in disrupting oncogenes, boosting tumor-suppressor genes, and engineering CAR-T cells for more effective immunotherapy. As clinical trials advance, CRISPR holds promise for personalized cancer treatments, offering a new era of precision medicine with fewer side effects and improved patient outcomes.

    Related Conference of Gene Editing & CRISPR in Cancer

    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Gene Editing & CRISPR in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in